Increase/Decrease in Cash: The total change in cash for the company over the given period.
bioMerieux (BMXMF) had Increase/Decrease in Cash of $139.16M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$4.60B |
|
$449.73M |
|
$1.99B |
|
$2.61B |
|
$4.01B |
|
$589.91M |
|
$4.98M |
|
$594.78M |
|
$594.78M |
|
$449.05M |
|
$449.05M |
|
$449.05M |
|
$449.05M |
|
$589.91M |
|
$1.09B |
|
117.95M |
|
119.01M |
|
$3.81 |
|
$3.78 |
|
| Balance Sheet Financials | |
$2.87B |
|
$1.72B |
|
$3.43B |
|
$6.31B |
|
$1.20B |
|
$373.36M |
|
$457.09M |
|
$1.66B |
|
$4.65B |
|
$3.37B |
|
$4.65B |
|
-- |
|
| Cash Flow Statement Financials | |
$891.88M |
|
$-522.37M |
|
$-175.82M |
|
$500.19M |
|
$639.35M |
|
|
Increase/Decrease in Cash |
$139.16M |
$29.98M |
|
$-120.04M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|